| P2093 | author name string | Benson WE | |
| | Murphy RP | |
| | Williams GA | |
| | Frambach DA | |
| | Kreiger AE | |
| | Bloome MA | |
| | Fong DS | |
| | Cruickshanks KC | |
| P2860 | cites work | Comparison of recombinant transforming growth factor-beta-2 and placebo as an adjunctive agent for macular hole surgery | Q74449307 |
| | Macular hole surgery using thrombin-activated fibrinogen and selective removal of the internal limiting membrane | Q77213180 |
| | Plasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes | Q77352397 |
| | Reopening of macular holes after initially successful repair | Q77459881 |
| | Visual function and patient satisfaction after macular hole surgery | Q77670664 |
| | Macular hole surgery with internal-limiting membrane peeling and intravitreous air | Q78002502 |
| | Macular hole formation: new data provided by optical coherence tomography | Q30578239 |
| | Macular hole surgery with and without internal limiting membrane peeling | Q30933864 |
| | Foveal pseudocyst as the first step in macular hole formation: a prospective study by optical coherence tomography | Q31812988 |
| | Internal limiting membrane removal in the management of full-thickness macular holes | Q33991648 |
| | Surgical management of macular holes: results using gas tamponade alone, or in combination with autologous platelet concentrate, or transforming growth factor beta 2. | Q35299096 |
| | Bilaterality of idiopathic macular holes | Q41268467 |
| | A multicentered clinical study of serum as adjuvant therapy for surgical treatment of macular holes. Vitrectomy for Macular Hole Study Group | Q41702931 |
| | Incidence of idiopathic full-thickness macular holes in fellow eyes. A 5-year prospective natural history study. | Q41710449 |
| | Silicone oil tamponade to seal macular holes without position restrictions | Q43472234 |
| | Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Results of a multicentered randomized clinical trial. The Vitrectomy for Treatment of Macular Hole Study Group. | Q43528917 |
| | Vision-threatening complications of surgery for full-thickness macular holes. Vitrectomy for Macular Hole Study Group. | Q45998531 |
| | Macular hole surgery without face-down positioning. A pilot study | Q46267129 |
| | Prospective randomized trial of vitrectomy or observation for stage 2 macular holes. Vitrectomy for Macular Hole Study Group | Q46595971 |
| | Distribution of iatrogenic retinal breaks in macular hole surgery | Q47195135 |
| | Surgical treatment of full-thickness macular holes using autologous serum. | Q50983287 |
| | Surgical closure of macular hole using an absorbable macular plug. | Q53607768 |
| | Late re-opening of macular holes after initially successful treatment with vitreous surgery. | Q54025542 |
| | Bilateral visual function after macular hole surgery. | Q64928961 |
| | Idiopathic senile macular hole. Its early stages and pathogenesis | Q68320462 |
| | Vitreous surgery for idiopathic macular holes. Results of a pilot study | Q70145928 |
| | The effect of pars plana vitrectomy and transforming growth factor-beta 2 without epiretinal membrane peeling on full-thickness macular holes | Q70760006 |
| | Success with macular hole surgery | Q70985067 |
| | Intraocular tamponade duration and success of macular hole surgery | Q71767754 |
| | Macular hole surgery. Comparison of longstanding versus recent macular holes | Q71832999 |
| | Vitrectomy for prevention of macular holes. Results of a randomized multicenter clinical trial. Vitrectomy for Prevention of Macular Hole Study Group | Q72006846 |
| | Optical coherence tomography of macular holes | Q72303342 |
| | Posterior segment complications after vitrectomy for macular hole | Q72303353 |
| | Reappraisal of biomicroscopic classification of stages of development of a macular hole | Q72324397 |
| | Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes | Q72419475 |
| | Results of surgical treatment of recent-onset full-thickness idiopathic macular holes | Q72889814 |
| | Thrombin in the management of full thickness macular holes | Q72993610 |
| | The macular hole: report of an Australian surgical series and meta-analysis of the literature | Q73047742 |
| | Human autologous serum for the treatment of full-thickness macular holes. A preliminary study | Q73274976 |
| | Effect of perifoveal tissue dissection in the management of acute idiopathic full-thickness macular holes | Q73678928 |
| | Long-term incidence of reopening of macular holes | Q73683831 |
| | Diamond-dusted silicone cannula for epiretinal membrane separation during vitreous surgery | Q73765957 |
| | Long-term visual outcomes in patients with successful macular hole surgery | Q73790011 |
| | Treatment of full-thickness macular holes with autologous serum | Q73861873 |
| | Use of autologous platelet concentrate in macular hole surgery: report of 77 cases | Q73980449 |
| | Autologous platelet concentrate in the surgical management of macular holes | Q73980451 |
| P433 | issue | 7 | |
| P304 | page(s) | 1328-1335 | |
| P577 | publication date | 2001-07-01 | |
| P1433 | published in | Ophthalmology | Q7098109 |
| P1476 | title | Surgical management of macular holes: a report by the American Academy of Ophthalmology | |
| P478 | volume | 108 | |